Cargando…

CYP2C19 genotypes and osteoporotic fractures in long‐term users of proton pump inhibitors: A hospital‐based study

Proton pump inhibitors (PPIs) are commonly prescribed medications. The existing data suggest that individuals at a high risk of fractures have been exposed to high doses of PPIs for prolonged durations. CYP2C19 plays a pivotal role in metabolism of PPIs and thereby influences their pharmacokinetic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Yi‐Ju, Chen, Yu‐Ting, Hsiao, Tzu‐Hung, Lin, Ching‐Heng, Wu, Ming‐Fen, Hsu, Chiann‐Yi, Chen, Yi‐Ming, Hsu, Chun‐Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651637/ https://www.ncbi.nlm.nih.gov/pubmed/37641483 http://dx.doi.org/10.1111/cts.13620

Ejemplares similares

Clopidogrel Use and CYP2C19 Genotypes in Patients Undergoing Vascular Intervention Procedure: A Hospital-Based Study
por: Liao, Yi-Ju, et al.
Publicado: (2022)

CYP2C19 loss-of-function alleles predicts clinical outcomes in East Asian patients with acute myocardial infarction undergoing percutaneous coronary intervention and stenting receiving clopidogrel
por: Chen, Yu-Wei, et al.
Publicado: (2022)

Enhanced Risk of Osteoporotic Fracture in Patients with Sarcopenia: A National Population-Based Study in Taiwan
por: Zhang, Han-Wei, et al.
Publicado: (2022)

Associations between Antibiotics for Non-tuberculous Mycobacterial Infection and Incident Sjögren’s Syndrome: A Nationwide, Population-based Case-control Study
por: Chao, Wen-Cheng, et al.
Publicado: (2018)

Utilizing apolipoprotein E genotypes and associated comorbidities for the assessment of the risk for dementia
por: Tung, Hsin, et al.
Publicado: (2022)

Proton Pump Inhibitors Increase the Risk of Autoimmune Diseases: A Nationwide Cohort Study
por: Lin, Sheng-Hong, et al.
Publicado: (2021)

The risk of nontuberculous mycobacterial infection in patients with Sjögren’s syndrome: a nationwide, population-based cohort study
por: Chao, Wen-Cheng, et al.
Publicado: (2017)

HIV-1 CRF07_BC Infections, Injecting Drug Users, Taiwan
por: Chen, Yi-Ming Arthur, et al.
Publicado: (2006)

Proton pump inhibitor use and the risk for Parkinson’s disease: A nationwide population-based study in Taiwan
por: Chen, Huan-Lin, et al.
Publicado: (2023)

Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
por: Fang, Yu-Hung, et al.
Publicado: (2019)

Risk Factors and Incidence of Repeat Osteoporotic Fractures Among the Elderly in Taiwan: A Population-based Cohort Study
por: Hsiao, Peng-Ching, et al.
Publicado: (2015)

Proton pump inhibitors use is associated with a lower risk of acute exacerbation and mortality in patients with coexistent COPD and GERD
por: Su, Vincent Yi-Fong, et al.
Publicado: (2018)

Proton pump inhibitors and risk of periampullary cancers—A nested case–control study
por: Chien, Li‐Nien, et al.
Publicado: (2015)

Risk of Pyogenic Liver Abscess in Proton Pump Inhibitor Users: New Inventory of Proton Pump Inhibitor Induced Complications?
por: Bang, Ki Bae
Publicado: (2021)

Evaluation of symptomatic reflux esophagitis in proton pump inhibitor users
por: Asaoka, Daisuke, et al.
Publicado: (2019)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Clinical Outcomes of Neoadjuvant Therapy in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients: A Single-Center Retrospective Study
por: Hung, Chih-Chiang, et al.
Publicado: (2022)

Efficacy of alfacalcidol and alendronate on lumbar bone mineral density in osteoporotic patients using proton pump inhibitors
por: Asaoka, Daisuke, et al.
Publicado: (2016)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

Remission and long-term remission of pediatric-onset systemic lupus erythematosus
por: Chen, Yi-Chieh, et al.
Publicado: (2023)

Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine
por: El Rouby, Nihal, et al.
Publicado: (2018)

Performance of Scoring Systems in Predicting Clinical Outcomes in Patients with Bacteremia of Listeria monocytogenes: A 9-Year Hospital-Based Study
por: Huang, Shang-Hsuan, et al.
Publicado: (2021)

Proton Pump Inhibitor-unresponsive Laryngeal Symptoms Are Associated With Psychological Comorbidities and Sleep Disturbance: A Manometry and Impedance-pH Monitoring Study
por: Tseng, Wen-Hsuan, et al.
Publicado: (2023)

Therapeutic Effects of Robotic-Exoskeleton-Assisted Gait Rehabilitation and Predictive Factors of Significant Improvements in Stroke Patients: A Randomized Controlled Trial
por: Lee, Yi-Heng, et al.
Publicado: (2023)

Extracorporeal shockwave therapy in osteoporotic osteoarthritis of the knee in rats: an experiment in animals
por: Wang, Ching-Jen, et al.
Publicado: (2014)

Combination of long- and short-axis alar sacroplasty techniques under fluoroscopic guidance for osteoporotic sacral insufficiency fracture
por: Kao, Feng-Chen, et al.
Publicado: (2021)

Intramedullary cortical bone strut improves the cyclic stability of osteoporotic proximal humeral fractures
por: Hsiao, Chih-Kun, et al.
Publicado: (2017)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
por: Westergaard, Niels, et al.
Publicado: (2021)

Low Bone Mineral Density and Calcium Levels as Risks for Mortality in Patients with Self-Discontinuation of Anti-Osteoporosis Medication
por: Hsu, Chun-Sheng, et al.
Publicado: (2021)

GRAde: a long-read sequencing approach to efficiently identifying the CYP11B1/CYP11B2 chimeric form in patients with glucocorticoid-remediable aldosteronism
por: Wu, Yu-Ching, et al.
Publicado: (2022)

Clinicopathologic Features of Lymphoproliferative Neoplasms Involving the Liver
por: Chiang, I, et al.
Publicado: (2022)

In Situ Creation of Surface-Enhanced Raman Scattering Active Au–AuO(x) Nanostructures through Electrochemical Process for Pigment Detection
por: Chen, Hsiao-Chien, et al.
Publicado: (2018)

The Influence of CYP3A4 Genetic Polymorphism and Proton Pump Inhibitors on Osimertinib Metabolism
por: Gao, Nanyong, et al.
Publicado: (2022)

Use of proton pump inhibitors for the risk of gastric cancer
por: Gao, Huiqin, et al.
Publicado: (2022)

Demoralization and Its Association with Quality of Life, Sleep Quality, Spiritual Interests, and Suicide Risk in Breast Cancer Inpatients: A Cross-Sectional Study
por: Chang, Ting-Gang, et al.
Publicado: (2022)

The monomeric form of Neisseria DNA mimic protein DMP19 prevents DNA from binding to the histone-like HU protein
por: Huang, Ming-Fen, et al.
Publicado: (2017)

Association of CYP2C19 Polymorphism With Proton Pump Inhibitors Effectiveness and With Fractures in Real‐Life: Retrospective Cohort Study
por: Gronich, Naomi, et al.
Publicado: (2022)

Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands
por: Chau, Sek Hung, et al.
Publicado: (2017)

Biological interactions of CYP2C19 genotypes with CYP3A4*18, CYP3A5*3, and MDR1-3435 in living donor liver transplantation recipients
por: Chiu, King-Wah, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_8uaob3p869qf54ov3v7vk217vt